Crossmark

Seguridad y efectividad del tratamiento con elexacaftor, tezacaftor e ivacaftor en adultos con fibrosis quística

Crossref DOI link: https://doi.org/10.1016/j.medcli.2023.06.003

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Nieto Royo, Rosa

Durán Barata, Diego

Barrios Barreto, Deisy

Briceño Franquiz, Winnifer

Máiz Carro, Luis
License Information

Text and Data Mining valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01
More Information

This article is maintained by: Elsevier

Article Title: Seguridad y efectividad del tratamiento con elexacaftor, tezacaftor e ivacaftor en adultos con fibrosis quística

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2023.06.003

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.